SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-269431
Filing Date
2023-11-02
Accepted
2023-11-02 16:39:34
Documents
10
Effectiveness Date
2023-11-02

Document Format Files

Seq Description Document Type Size
1 S-3ASR d557670ds3asr.htm S-3ASR 499881
2 EX-4.8 d557670dex48.htm EX-4.8 315068
3 EX-4.11 d557670dex411.htm EX-4.11 101649
4 EX-4.12 d557670dex412.htm EX-4.12 101813
5 EX-4.13 d557670dex413.htm EX-4.13 91170
6 EX-5.1 d557670dex51.htm EX-5.1 28017
7 EX-23.1 d557670dex231.htm EX-23.1 1981
8 EX-FILING FEES d557670dexfilingfees.htm EX-FILING FEES 53570
9 GRAPHIC g557670g1102115232827.jpg GRAPHIC 2533
10 GRAPHIC g557670g82e20.jpg GRAPHIC 35325
  Complete submission text file 0001193125-23-269431.txt   1246717
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-275279 | Film No.: 231373101
SIC: 2834 Pharmaceutical Preparations